Focus Partners Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.9M Buy
624,337
+65,636
+12% +$3.83M 0.04% 348
2025
Q4
$30.1M Buy
558,701
+339,041
+154% +$16.3M 0.03% 396
2025
Q3
$9.91M Buy
219,660
+12,029
+6% +$562K 0.02% 561
2025
Q2
$9.61M Sell
207,631
-10,455
-5% -$513K 0.02% 507
2025
Q1
$13.3M Sell
218,086
-8,352
-4% -$487K 0.03% 416
2024
Q4
$12.8M Buy
226,438
+43,334
+24% +$2.42M 0.03% 404
2024
Q3
$9.47M Sell
183,104
-98,888
-35% -$4.64M 0.03% 414
2024
Q2
$11.7M Buy
281,992
+74,471
+36% +$3.33M 0.04% 350
2024
Q1
$11.3M Sell
207,521
-1,290
-0.6% -$65.7K 0.09% 203
2023
Q4
$10.7M Buy
+208,811
New +$11M 0.14% 144

Other funds holding BMY

Focus Partners Wealth's BMY Position: Q1 2026 in Review

Focus Partners Wealth increased its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, buying an estimated $3.83M and bringing the position to 624,337 shares worth $37.9M. The position accounts for 0.04% of the portfolio, ranked #348.

Focus Partners Wealth first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Focus Partners Wealth held 624,337 shares of Bristol-Myers Squibb worth $37.9M as of Q1 2026.
  • Focus Partners Wealth bought 65,636 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.83M.
  • Bristol-Myers Squibb made up 0.04% of Focus Partners Wealth's portfolio in Q1 2026, its #348 holding.
  • Focus Partners Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.